No Image Available

Meningo-Coccal Polysaccharide Diphtheria Toxoid Conjugate

Form: Injection

Strength: 0.5ML

Reference Brands:

Category: Vaccines

Meningococcal infection can cause life-threatening illnesses, such as meningococcal meningitis, which affects the brain, and meningococcemia, which affects the blood. Some persons with meningococcal meningitis and/or meningococcemia may die. The rate of these diseases peak in adolescence and early adulthood and are more likely to occur in persons with certain diseases or conditions that make them more susceptible to a meningococcal infection or more likely to develop serious problems from a meningococcal infection.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Inactivated Vaccines

Strength: Dose and concentration depend on formulations

Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution

Reference Brands: Sinovac Coronavac. Covaxin(EU)

View Details
Viral Vector Vaccines

Strength: 0.5 mL

Form: Intramuscular injectable suspension (IM)

Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)

View Details
Mrna-Based Vaccines

Strength: 30 µg and 100 µg

Form: Injectable suspension

Reference Brands: Comirnaty, Spikevax(US)

View Details
Meningococcal Vaccine

Strength: 0.5 mL

Form: Vial or pre-filled syringe (injectable), Conjugate vaccines

Reference Brands: Menactra, Menveo(US)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.